IONIS-GCGRRx

N/A

Report date: 2022/03/02 17:03:30
NME

Base Information

Drug NameIONIS-GCGRRx
Drug Alias NameIONIS-GCGRRxISIS-449884ISISGCGRRx
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionGlucagon receptor antagonists
TargetsGlucagon receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsSouth Africa +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesRuibo (Hong Kong) Biotechnology Co LtdSuzhou Ruibo Biotechnology Co Ltd
Inactive CompaniesIonis Pharmaceuticals Inc
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A